Document:

Amendment Number One to Non-Exclusive Distribution Agreement

 Exhibit 10.26 
 ***** CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH
RESPECT TO THE OMITTED PORTIONS. 
 Amendment Number One to Non-Exclusive Distribution Agreement 

This Amendment Number One to the Non-Exclusive Distribution Agreement (“Amendment Number One”) is made as of March 29,
2011, by and between DexCom, Inc., a Delaware corporation, with a principal place of business at 6340 Sequence Drive, San Diego, California 92121 (the "Company") and RGH Enterprises, Inc., an Ohio corporation with offices at 1810 Summit Commerce
Park, Twinsburg, Ohio 44087 (the “Distributor”). 
 WITNESSETH 

WHEREAS, Company and Distributor previously entered into a Non-Exclusive Distribution Agreement, effective April 30, 2008 (the
“Agreement”). 
 WHEREAS, Company and Distributor wish to amend the Agreement as set forth herein in accordance with
Section 6.1 and 16.9 of the Agreement. 
 THEREFORE, Company and Distributor agree as follows: 

1. Schedule 1. Schedule 1 shall be replaced in its entirety as follows: 

SCHEDULE 1 

The Products and the Prices 
 [*****] 
 SEVEN PLUS 

 

					
	 Product SKU
	  	 Product Description
	  	 [*****]

	 [*****]
	  	SEVEN PLUS Starter Kit[*****]	  	[*****]
			
	 [*****]
	  	SEVEN Sensors (package of four (4)) [*****]	  	[*****]
			
	 [*****]
	  	SEVEN PLUS Replacement Receiver[*****]	  	[*****]
			
	 [*****]
	  	SEVEN PLUS Replacement Transmitter[*****]	  	[*****]

 [*****] 

[*****] 
 2.
Section 4. A new section 4.1.29 shall be added as follows: 

  
 1 

 ***** CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED
WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

4.1.29. not to stock more than [*****]of Sensor inventory; provided however that Company acknowledges that, from time to time,
Distributor may stock an amount of Sensor inventory equal to more than [*****]based on demand fluctuations. Distributor also agrees not to sell any Sensors where the shelf-life on the Sensors is less than the time of reasonable consumption by
the Customer, and in no instance to ship Sensors with a shelf-life of less than [*****]. 
 3.
Section 4. A new section 4.1.30 shall be added as follows: 
 4.1.30. in material respects, to ship Sensors to
Customer within 3 business days of receiving prior authorization approval from the Customer’s insurance company, or in the alternative, upon notice of a denial of a prior authorization request, to inform the Company within 24 hours of such
denial. 
 4. Section 4. A new section 4.1.31 shall be added as follows: 

4.1.31. to provide, within seven days of the end of each calendar month, a report detailing Distributor’s month-end inventory balance
of Sensors (which report Company shall retain the right to audit on a periodic basis with advance notice to Distributor). 

5. Section 4. A new section 4.1.32 shall be added as follows: 

4.1.32. To ensure that Company can provide adequate adverse event reporting or to ensure that Company can complete any required remedial
action or product recall within timeframes required by law, Distributor agrees to provide device tracking reports in accordance with the applicable provisions of the Health Insurance Portability and Accountability Act Privacy and Security Standards
(HIPAA). In furtherance of this purpose, Distributor agrees to provide, as soon as reasonably possible, but in no less than two business days from request by Company, all relevant patient information necessary to provide adequate service to a
patient who presents issues requiring regulatory filings or response, or technical support. 
 6. Section 4.
A new section 4.1.33 shall be added as follows: 
 4.1.33 to provide, within seven days of the end of each calendar month, a
report containing the detail required under Schedule 4 hereof. 
 7. Section 4. A new section 4.1.34
shall be added as follows: 
 4.1.34. to comply with the requirements of the Quality Agreement set forth in Schedule 5
hereof. 

  
 2 

 8. Section 4. A new section 4.1.35 shall be added as follows:

 4.1.35. For so long as the pricing set forth in Schedule 1 hereof does not increase with respect to the SEVEN PLUS Starter
Kits and Sensors, Distributor agrees not to knowingly initiate any attempts or offers to switch any existing Distributor customer who use the Products to products of any other manufacturer without written consent from the Company. Absent medical or
clinical necessity to do so, any such attempt or offer to switch existing Distributor customers who use the Products to any other manufacturer’s products may render this Agreement immediately terminable by Company after discussions between the
Company and Distributor to ascertain the root cause of such attempts. 
 9. Section 4. A new section 4.1.36 shall
be added as follows: 
 4.1.36. to provide the Company with forecasts by Product in accordance with requirements set
forth in Schedule 6. 
 10. Section 5. A new section 5.1.4 shall be added as follows: 

5.1.4. to stock Sensors with Distributor based on purchase orders submitted by Distributor and to ship Sensors to Distributor consistent
with Schedule 6. 
 11. Section 11. Sections 11.1 and 11.2 shall be amended and replaced in its entirety by
the following: 
 Section 11.1. The term of this Agreement, as amended, shall extend for a period of twenty-four months from
the date of this Amendment Number One, and shall automatically renew for successive one (1) year renewal periods (the “Term”), provided that either Party may elect not to renew the Agreement by providing not less than ninety
(90) days prior written notice to that effect to the other Party. The Parties may at any time agree in writing to extend the Term or to renew this Agreement. 
 Section 11.2. Either party may terminate this Agreement immediately, by providing written notice to the other party in the event of any of the following events: 

Section 11.2.1. the other party is in breach of this Agreement and has not remedied such breach within thirty (30) days of
receiving written notice from the non-breaching party to do so, or within fifteen (15) days with respect to Section 4.1.33 of this Agreement regarding the provision of sales and warranty replacement reports; 

Section 11.2.2. the effective control of the Distributor shall change, to the extent that such Distributor change of control would
negatively impact its 

  
 3 

 
credit or would negatively impact its ability to service and market the Products; or 
 Section 11.2.3. the other party shall become insolvent or have a receiver appointed of its business or go into liquidation (except for the purposes of amalgamation or reorganization). 

In addition, either party may terminate the Agreement in the event that, after good faith negotiations, the parties are unable to reform
this Agreement as necessary to comply with applicable law, regulations, or governmental guidance (the “Law”). Before termination, the parties shall, in good faith, immediately renegotiate or reform this Agreement as necessary to comply
with the Law and to preserve the intent of this Agreement consistent with the requirements of the Law. 
 12. Sections
16.1 shall be amended and replaced in its entirety by the following: 
 Section 16.1. Notice. Any notice or other
communication required or permitted to be given under this Agreement shall be properly served only if it is in writing addressed as set out below. Notice may be sent by any of the following methods: (i) personal delivery; (ii) nationally
recognized overnight courier service; (iii) U.S. Postal Service certified or registered mail, return receipt requested, postage prepaid. Service shall be deemed to have been duly given on the date of delivery. Either party may change the names,
addresses and facsimile numbers for receipt of notice by complying with this Section 16.1. 
  

			
	If to the Company:	  	DexCom, Inc.
		  	6340 Sequence Drive
		  	San Diego, CA 92121
		  	Attn: President
		
	With a copy to	  	DexCom, Inc.
		  	6340 Sequence Drive
		  	San Diego, CA 92121
		  	Attn: Legal Department
		  	(858) 200-0200
		
	If to the Distributor:	  	RGH Enterprise, Inc
		  	1810 Summit Commerce Park
		  	Twinsburg, Ohio 44087
		  	Attn: President
		
	with a copy to:	  	Walter & Haverfield
		  	The Tower at Erieview
		  	1301 E. Ninth St, Ste 3500
		  	Cleveland, Ohio 44114
		  	Attn: Robert Crump

  
 4 

 ***** CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED
WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

13. Schedule 3. Schedule 3 shall be amended and replaced in its entirety as follows: 

SCHEDULE 3 
 Care Coordination
Report Format 
 For first-time orders [*****], Distributor shall provide the following information to Company for the purpose of
coordinating set up, consulting with the prescribing physician as needed to recommend any changes, and providing patient and/or caregiver training on the safe and effective use of the Seven Plus continuous glucose monitoring system: 

Distributor shall waive any and all fees in connection with providing the information required by this report to Company. 

New Patient and Starter Kit [*****] 

Required Reporting Frequency: Daily 
 Required
Reporting Method or Venue: Web-portal 
 File Type: csv 
 De-limiting character: “,” comma with values enclosed by Quotation Marks 
 Subject to
compliance with the applicable provisions of HIPAA, the Care Coordination Reports should adhere to the following format & should not-deviate in order from one report to the next: 
 Status 
 Patient 
 Referral 
 MFG Acct # 
 Date Rec. 
 Contact Date 
 Touch Date 
 Comments 
 F/U Date 
 Ship Date 
 Cancel Date 
 Ins Name 
 Phys Name 
 Phys City 
 Phys State 
 Phys Zip 

  
 5 

 Phys Phone 
 Patient Address 
 Patient City 
 Patient State 
 Patient Zip 
 Patient Phone 
 Patient DOB 
 Serial No. 
 Part No. 
 Quantity 
 [REMAINDER OF PAGE LEFT INTENTIONALLY BLANK] 

  
 6 

 14. Schedule 4. A new Schedule 4 shall be added as follows: 

Distributor Healthcare Operations Improvement Report 
 The parties shall share information for the purpose of conducting patient safety, quality assessment and improvement activities and evaluating the necessity of physician and health plan feedback. To the
extent any of the information Distributor reports to Company is protected health information under HIPAA (“PHI”), Company will not use or further disclose the PHI, including re-identifying any individuals or contacting any individuals who
are the subject of the PHI, other than as permitted or required by law and this Agreement. 
 Distributor shall provide to
Company a report within seven business days after the end of each calendar month that details the following: 
  

	 	1.	Limited Data Set that includes the following fields: 

  

	 	a.	ID 

  

	 	b.	Physician Name 

  

	 	c.	Physician Zip 

  

	 	d.	NPI 

  

	 	e.	Insurance 

  

	 	f.	Item 

  

	 	g.	Item Quantity 

  

	 	h.	Unit of Measure 

  

	 	i.	Insurance Name 

  

	 	j.	Date of Service 

 Distributor
shall provide to Company a report within fifteen days after the end of each calendar quarter that details the following: 
  

	 	1.	The twelve month rolling attrition rate with respect to Distributor’s patients who have used the Products. 

 

	 	2.	The twelve month rolling Sensor utilization rate with respect to Distributor’s patients who have used the Products. 

  
 7 

 15. Schedule 5. A new Schedule 5 shall be added as follows: 

Quality Agreement 
  

	1.0	SCOPE 

  

	 	1.1	This Quality Agreement (the “Quality Agreement”) is incorporated within the Distribution Agreement that was effective April 30, 2008, as amended, between
Distributor and Company pertaining to the distribution and sale of Products (the “Agreement”). Capitalized terms not otherwise defined herein shall have the meaning assigned to them in the Agreement. To the extent the terms of the Quality
Agreement and the Agreement conflict, the terms set forth in the Quality Agreement shall superseded the Agreement. 

  

	 	1.2	This Quality Agreement shall be effective on the Effective Date and shall remain in effect until the Agreement expires, is terminated or the Quality Agreement is
modified. 

  

	2.0	PROCESS CONTROLS 

  

	 	2.1	Distributor shall be responsible for supplier appropriate process control activities relative to the Products, including but not limited to, assurance of receipt,
identification, traceability, storage, handling, inventory control and facility contamination control. 

  

	 	2.2	Company shall provide evidence that packaging containers maintain the integrity, quality, function, and sterility of the product for the entire shelf life, and not
produce toxic residues during storage. Packaging must prevent or indicate the occurrence of tampering. 

  

	3.0	TRAINING AND DOCUMENT CHANGE CONTROL 

  

	 	3.1	Distributor must train its employees to perform their job function and to this Quality Agreement as required. 

 

	4.0	QUALIFICATION 

  

	 	4.1	Distributor shall be responsible for managing qualified processes and systems as required of suppliers (e.g. computer system) by law. 

 

	5.0	DISTRIBUTION AND HANDLING 

  

	 	5.1	Products shipped by the Distributor must be shipped using standard procedures for the handling, storage, packaging, preservation, and delivery of the Products.

  

	 	5.2	Distributor shall deliver Products to its customers using standard procedures for handling, storage, packing, preservation, and delivery of the Products.

  

	6.0	LOT TRACEABILITY 

  
 8 

 ***** CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED
WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 
  

	 	6.1	Distributor shall establish and maintain appropriate procedures for identifying the Products by suitable means from receipt and during all stages of delivery.

  

					
	 Product
	  	 Description
	  	 Lot traceability Tracking
Requirement

	[*****]	  	SEVEN PLUS System Kit	  	Lot Number identified on the box
			
	[*****]	  	SEVEN Sensors (package of four (4))	  	Lot Number identified on the box
			
	[*****]	  	SEVEN PLUS Replacement Receiver	  	Lot Number identified on the box
			
	[*****]	  	SEVEN PLUS Replacement Transmitter	  	Lot Number identified on the box

  

	7.0	PACKAGING AND LABELING 

  

	 	7.1	Company shall provide packaging and labeling specifications that call out clear labeling requirements. 

 

	 	7.2	Company shall ensure that the labels, inserts and accompanying documentation satisfy the requirements of the applicable regulations. 

 

	8.0	COMPLAINT HANDLING AND REPORTING 

  

	 	8.1	Distributor shall be responsible for the establishment and maintenance of a system for handling complaints pertaining to the process of distributing Products under the
Agreement pursuant to current Distributor policy. This system shall include receipt, review, corrective/preventative action and maintenance of files. Distributor will not knowingly perform any Device Complaint handling, as defined below.

  

	 	8.2	Company shall be responsible for the establishment and maintenance of a system for handling Device Complaints pertaining to Products distributed under the Agreement. A
“Device Complaint” includes complaints that pertain to Product functionality, trouble shooting, or adverse events. This system shall include receipt, review, investigation, corrective/preventative action and maintenance of files.

  

	 	8.3	Company shall notify Distributor in writing of legal and regulatory matters relating to the Products, including: 

 

	 	8.3.1	Any regulatory actions by governmental authorities (e.g., inspection citations, warning letters, or other non-conformance notices). 

 

	 	8.3.2	Regulatory enforcement actions such as injunctions or seizures. 

  

	 	8.3.3	FDA registration activity (e.g., non-conformance notices, hold points). 

  

	 	8.3.4	Complaints received from Customers within the Territory that have not been processed through the Company’s complaint handling system. 

  
 9 

 ***** CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED
WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 
  

	 	8.3.5	Adverse incidents relating to Customers within the Territory (e.g., MDR’s.). 

 

	 	8.4	Distributor shall notify Company in writing of the following: 

  

	 	8.4.1	Any serious regulatory action relating to the Products that Distributor may become aware of. 

 

	 	8.4.2	Escalated Complaints regarding Products or Instruments. Distributor shall code, trend and report monthly Escalated Complaint data pertaining to Products, at
Distributor’s request. 

  

	 	8.4.3	Distributor shall forward all complaints pertaining to Products and Instruments to Company no later than 10 working days following Distributor’s initial receipt of
the complaint. 

  

	9.0	FIELD ACTIONS 

  

	 	9.1	The Company will be responsible for the initiation and cost of any recalls or other field actions related to the Products. 

 

	 	9.2	Both parties will comply with recalls or general corrective actions, provided such recalls or general corrective actions do not, in the opinion of Company violate or
cause Company to violate the laws of any jurisdiction affected by the recalls or corrective action. 

  

	 	9.3	If Distributor and Company do not agree on a course of action, Company may initiate field actions related to the Products, but may not use field action to cause
Distributor to lose Customers or violate the law. 

  

	10.0	AUDITS 

  

	 	10.1	Company shall have the right to conduct audits of Distributor’s facilities and operations during normal business hours at its own expense and upon reasonable
notice to Distributor in order to assess compliance with all applicable regulations, procedures and this Quality Agreement. Any such audits will be conducted by a national “big four” independent accounting firm (or other independent
accounting firm whose audit department is a separate stand alone function of its business and which possesses liability insurance with coverage of at least $[*****]), subject to such firm’s execution of a confidentiality agreement in
form reasonably acceptable to Distributor. Company shall be permitted to conduct one audit per calendar year. 

  

	11.0	RECORD RETENTION 

  

	 	11.1	Both parties shall retain all medical records as required by law. 

  

	12.0	REGULATORY AND REGISTRATION ADMINISTRATION 

  

	 	12.1	Company, at its expense, is responsible for registration responsibilities, and for agreed upon registration costs of Products in the Territory. Company shall provide
sufficient data and information to support such registrations. 

  
 10 

	13.0	ADDITIONAL DISTRIBUTOR REQUIREMENTS 

Records should be accurate, indelible and legible. Entries must be dated and the person performing a documented task must be identified. Records must
provide a complete history of the work performed. 
 [REMAINDER OF PAGE LEFT INTENTIONALLY BLANK] 

  
 11 

 ***** CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED
WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

16. Schedule 6. A new Schedule 6 shall be added as follows: 

Schedule 6 

Forecast, Ordering and Acceptance Requirements 
 I. Forecast. Distributor shall deliver to Company its non-binding forecast (the “Forecast”) of the expected requirements for Products in the Territory for the
[*****]period following the Effective Date. Thereafter, Distributor shall update such Forecast on a monthly basis and provide it to Company at least five business days prior to the first of each month. 

II. Orders, Shipping. Orders will be initiated by a written order, electronic equivalent or facsimile issued to DexCom (the
“Order”). Each Order shall include information as set forth in Schedule 2, and shall identify the Distributor depot to which the Products shall be shipped. Products shall be shipped on [*****], and shall be subject
to a minimum of [*****]lead time afforded to the Company, although the Company endeavors to ship Products within [*****]after its receipt of an Order. In addition, Distributor may request that Company ship Products directly to end user
customers, with costs of such shipments to be borne by Distributor. An Order shall be deemed to have been placed as of the date of receipt of the Order by Company. If Distributor requests Company to supply quantities in excess of quantity set
forth in the Forecast, Company shall endeavor reasonably within the constraints of its production schedules and other commitments to meet all or part of such requests, but Company shall have no obligation to supply such quantities within the
timeframes set forth herein. Where necessary, Company will advise Distributor of delivery dates and quantities for the portion of Order(s) in excess. All freight, insurance and other shipping expenses, as well as any special packing expenses,
will be paid by Distributor. 
 III. Acceptance. Within ten (10) days following a receipt of a shipment, Distributor shall
perform a visual inspection (in accordance with Distributor’s standard procedures) of the Products received and shall inform Company in writing of any non-conformity of the supplied Products to the Order or other defect in the
Products. In the absence of written notice to Company of a specified non-conformity within ten (10) business days of the end of such ten-day period, the Products shall be deemed to be accepted by Distributor. 

[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK] 

  
 12 

 18. All other terms and conditions of the Agreement shall remain in full force and
effect. 
 IN WITNESS WHEREOF, authorized representatives of the parties have executed this Amendment Number One as of date first set out
above. 
  

			
	Signed by:	 	/s/ Jess Roper
		 	Jess Roper
	Title: V.P. and Chief Financial Officer

 for and
on behalf of 
 DexCom, Inc. 
  

			
		
	Signed by:	 	/s/ Chris Lindroth
	 Name:
 Title:
	 	 Chris Lindroth
 Executive
Vice President

 for and on behalf of 
 RGH Enterprises, Inc. 

  
 13Long-Term Incentive Plan

 Exhibit 10.4 
 O’DONNELL STRATEGIC INDUSTRIAL REIT, INC. 
 LONG TERM INCENTIVE PLAN

 O’DONNELL STRATEGIC INDUSTRIAL REIT, INC. 

LONG TERM INCENTIVE PLAN 
  

							
	ARTICLE 1	  	PURPOSE	  	 	1	  
			
	            1.1	  	General	  	 	1	  
			
	ARTICLE 2	  	DEFINITIONS	  	 	1	  
			
	            2.1	  	Definitions	  	 	1	  
			
	ARTICLE 3	  	PLAN EFFECTIVE DATE; TERMINATION OF PLAN	  	 	6	  
			
	            3.1	  	Plan Effective Date	  	 	6	  
	            3.2	  	Termination of Plan	  	 	6	  
			
	ARTICLE 4	  	ADMINISTRATION	  	 	6	  
			
	            4.1	  	Committee	  	 	6	  
	            4.2	  	Actions and Interpretations by the Committee	  	 	7	  
	            4.3	  	Authority of Committee	  	 	7	  
	            4.4	  	Award Certificates	  	 	7	  
			
	ARTICLE 5	  	SHARES SUBJECT TO THE PLAN	  	 	8	  
			
	            5.1	  	Number of Shares	  	 	8	  
	            5.2	  	Share Counting	  	 	8	  
	            5.3	  	Stock Distributed	  	 	8	  
			
	ARTICLE 6	  	ELIGIBILITY	  	 	8	  
			
	            6.1	  	General	  	 	8	  
			
	ARTICLE 7	  	STOCK OPTIONS	  	 	9	  
			
	            7.1	  	General	  	 	9	  
	            7.2	  	Incentive Stock Options	  	 	9	  
			
	ARTICLE 8	  	STOCK APPRECIATION RIGHTS	  	 	9	  
			
	            8.1	  	Grant of Stock Appreciation Rights	  	 	9	  
			
	ARTICLE 9	  	RESTRICTED STOCK, RESTRICTED STOCK UNITS AND DEFERRED STOCK UNITS	  	 	10	  
			
	            9.1	  	Grant of Restricted Stock, Restricted Stock Units and Deferred Stock Units	  	 	10	  
	            9.2	  	Issuance and Restrictions	  	 	10	  
	            9.3	  	Dividends on Restricted Stock	  	 	11	  
	            9.4	  	Forfeiture	  	 	11	  
	            9.5	  	Delivery of Restricted Stock	  	 	11	  
			
	ARTICLE 10	  	PERFORMANCE AWARDS	  	 	11	  
			
	            10.1	  	Grant of Performance Awards	  	 	11	  
	            10.2	  	Performance Goals	  	 	11	  

  
 - i -

							
	 ARTICLE 11
	  	DIVIDEND EQUIVALENTS	  	 	12	  
			
	             11.1
	  	Grant of Dividend Equivalents	  	 	12	  
			
	 ARTICLE 12
	  	OTHER AWARDS	  	 	12	  
			
	             12.1
	  	Award Certificates	  	 	12	  
			
	 ARTICLE 13
	  	PROVISIONS APPLICABLE TO AWARDS	  	 	12	  
			
	             13.1
	  	Term of Awards	  	 	12	  
	             13.2
	  	Form of Payment for Awards	  	 	12	  
	             13.3
	  	Limits on Transfer	  	 	12	  
	             13.4
	  	Beneficiaries	  	 	13	  
	             13.5
	  	Stock Trading Restrictions	  	 	13	  
	             13.6
	  	Acceleration upon Death or Disability	  	 	13	  
	             13.7
	  	Acceleration upon a Change in Control	  	 	14	  
	             13.8
	  	Acceleration for Any Reason	  	 	14	  
	             13.9
	  	Forfeiture Events	  	 	14	  
	             13.10
	  	Substitute Awards	  	 	14	  
			
	 ARTICLE 14
	  	CHANGES IN CAPITAL STRUCTURE	  	 	15	  
			
	             14.1
	  	Mandatory Adjustments	  	 	15	  
	             14.2
	  	Discretionary Adjustments	  	 	15	  
	             14.3
	  	General	  	 	15	  
			
	 ARTICLE 15
	  	AMENDMENT, MODIFICATION AND TERMINATION	  	 	15	  
			
	             15.1
	  	Amendment, Modification and Termination	  	 	15	  
	             15.2
	  	Awards Previously Granted	  	 	16	  
	             15.3
	  	Compliance Amendments	  	 	16	  
			
	 ARTICLE 16
	  	GENERAL PROVISIONS	  	 	16	  
			
	             16.1
	  	Rights of Participants	  	 	16	  
	             16.2
	  	Withholding	  	 	17	  
	             16.3
	  	Special Provisions Related to Section 409A of the Code	  	 	17	  
	             16.4
	  	Unfunded Status of Awards	  	 	18	  
	             16.5
	  	Relationship to Other Benefits	  	 	18	  
	             16.6
	  	Expenses	  	 	18	  
	             16.7
	  	Titles and Headings	  	 	19	  
	             16.8
	  	Gender and Number	  	 	19	  
	             16.9
	  	Fractional Shares	  	 	19	  
	             16.10
	  	Government and Other Regulations	  	 	19	  
	             16.11
	  	Governing Law	  	 	19	  
	             16.12
	  	Additional Provisions	  	 	19	  
	             16.13
	  	No Limitations on Rights of Company	  	 	19	  
	             16.14
	  	Indemnification	  	 	20	  

  
 - ii -

 O’DONNELL STRATEGIC INDUSTRIAL REIT, INC. 

FORM OF LONG TERM INCENTIVE PLAN 
 ARTICLE 1 
 PURPOSE 

1.1. GENERAL. The purpose of the O’Donnell Strategic Industrial REIT, Inc. Long Term Incentive Plan (the
“Plan”) is to enable O’Donnell Strategic Industrial REIT, Inc. (the “Company”) and its Affiliates (as defined below) to (1) provide an incentive to employees, officers, directors, consultants and advisors
to increase the value of the Company’s common stock, (2) give such persons a stake in the Company’s future that corresponds to the stake of each of the Company’s stockholders, and (3) obtain or retain the services of these
persons who are considered essential to the Company’s long-term success, by offering such persons an opportunity to participate in the Company’s growth through ownership of the Company’s common stock or through other equity-related
awards. Accordingly, the Plan permits the grant of incentive awards from time to time to selected employees, officers, directors, consultants and advisors of the Company and its Affiliates. 

ARTICLE 2 

DEFINITIONS 
 2.1. DEFINITIONS. When a word or phrase appears in this Plan with the initial letter capitalized, and the word or phrase does not commence a sentence, the word or phrase shall generally be given
the meaning ascribed to it in this Section or in Section 1.1 unless a clearly different meaning is required by the context. The following words and phrases shall have the following meanings: 

(a) “Affiliate” means (i) any Subsidiary or Parent, or (ii) an entity that directly or through
one or more intermediaries controls, is controlled by or is under common control with, the Company, as determined by the Committee. 
 (b) “Award” means any Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Deferred Stock Unit, Performance Award, Dividend Equivalent, Other Award, or any other
right or interest relating to Stock or cash, granted to a Participant under the Plan. 
 (c) “Award
Certificate” means a written document, in such form as the Committee prescribes from time to time, setting forth the terms and conditions of an Award. Award Certificates may be in the form of individual award agreements or certificates or a
program document describing the terms and provisions of an Award or series of Awards under the Plan. The Committee may provide for the use of electronic, internet or other non-paper Award Certificates, and the use of electronic, internet or other
non-paper means for the acceptance thereof and actions thereunder by a Participant. 
 (d) “Beneficial
Owner” shall have the meaning given such term in Rule 13d-3 of the General Rules and Regulations under the 1934 Act. 
 (e) “Board” means the Board of Directors of the Company. 
 (f) “Cause” as a reason for a Participant’s termination of employment shall have the meaning assigned such term in the employment, severance or similar agreement, if any, between
such Participant and the Company or an Affiliate; provided, however, that if there is no such employment, severance or similar agreement in which such term is defined, and unless otherwise

 
defined in the applicable Award Certificate, “Cause” shall mean any of the following acts by the Participant, as determined by the Committee: gross neglect of duty, prolonged absence
from duty without the consent of the Company, material breach by the Participant of any published Company code of conduct or code of ethics; or willful misconduct, misfeasance or malfeasance of duty which is reasonably determined to be detrimental
to the Company. With respect to a Participant’s termination of directorship, “Cause” means an act or failure to act that constitutes cause for removal of a director under applicable Maryland law. The determination of the
Committee as to the existence of “Cause” shall be conclusive on the Participant and the Company. 
 (g)
“Change in Control” means and includes the occurrence of any one of the following events but shall specifically exclude a Public Offering: 
 (i) during any consecutive 12-month period, individuals who, at the beginning of such period, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least
a majority of such Board, provided that any person becoming a director after the beginning of such 12-month period and whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors then on the
Board shall be an Incumbent Director; provided, however, that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to the election or removal of
directors (“Election Contest”) or other actual or threatened solicitation of proxies or consents by or on behalf of any Person other than the Board (“Proxy Contest”), including by reason of any agreement intended to
avoid or settle any Election Contest or Proxy Contest, shall be deemed an Incumbent Director; or 
 (ii) any
Person becomes a Beneficial Owner, directly or indirectly, of either (A) 35% or more of the then-outstanding shares of common stock of the Company (“Company Common Stock”) or (B) securities of the Company representing 35%
or more of the combined voting power of the Company’s then outstanding securities eligible to vote for the election of directors (the “Company Voting Securities”); provided, however, that for purposes of this
subsection (ii), the following acquisitions of Company Common Stock or Company Voting Securities shall not constitute a Change in Control: (w) an acquisition directly from the Company, (x) an acquisition by the Company or a Subsidiary,
(y) an acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Subsidiary, or (z) an acquisition pursuant to a Non-Qualifying Transaction (as defined in subsection (iii) below); or

 (iii) the consummation of a reorganization, merger, consolidation, statutory share exchange or similar form of corporate
transaction involving the Company or a Subsidiary (a “Reorganization”), or the sale or other disposition of all or substantially all of the Company’s assets (a “Sale”) or the acquisition of assets or stock of
another corporation or other entity (an “Acquisition”), unless immediately following such Reorganization, Sale or Acquisition: (A) all or substantially all of the individuals and entities who were the Beneficial Owners,
respectively, of the outstanding Company Common Stock and outstanding Company Voting Securities immediately prior to such Reorganization, Sale or Acquisition beneficially own, directly or indirectly, more than 35% of, respectively, the then
outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the entity resulting from such Reorganization, Sale or
Acquisition (including, without limitation, an entity which as a result of such 

  
 2 

 
transaction owns the Company or all or substantially all of the Company’s assets or stock either directly or through one or more subsidiaries, the “Surviving Entity”) in
substantially the same proportions as their ownership, immediately prior to such Reorganization, Sale or Acquisition, of the outstanding Company Common Stock and the outstanding Company Voting Securities, as the case may be, and (B) no Person
(other than (x) the Company or any Subsidiary, (y) the Surviving Entity or its ultimate parent entity, or (z) any employee benefit plan (or related trust) sponsored or maintained by any of the foregoing) is the Beneficial Owner,
directly or indirectly, of 35% or more of the total common stock or 35% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Surviving Entity, and (C) at least a majority of the members of
the board of directors of the Surviving Entity were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Reorganization, Sale or Acquisition (any Reorganization, Sale or
Acquisition which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”); or 

(iv) approval by the stockholders of the Company of a complete liquidation or dissolution of the Company. 

(h) “Charter” means the articles of incorporation of the Company, as such articles of incorporation may
be amended from time to time. 
 (i) “Code” means the Internal Revenue Code of 1986, as amended
from time to time. For purposes of this Plan, references to sections of the Code shall be deemed to include references to any applicable regulations thereunder and any successor or similar provision. 

(j) “Committee” means the committee of the Board described in Article 4. 

(k) “Company” means O’Donnell Strategic Industrial REIT, Inc., a Maryland corporation, or any
successor corporation. 
 (l) “Continuous Status as a Participant” means the absence of any
interruption or termination of service as an employee, officer, director, or consultant of the Company or any Affiliate; provided, however, that for purposes of an Incentive Stock Option “Continuous Status as a Participant”
means the absence of any interruption or termination of service as an employee of the Company or any Parent or Subsidiary, as applicable, pursuant to applicable tax regulations. Continuous Status as a Participant shall not be considered interrupted
in the following cases: (i) a Participant transfers employment between the Company and an Affiliate or between Affiliates, or (ii) in the discretion of the Committee as specified at or prior to such occurrence, in the case of a spin-off,
sale or disposition of the Participant’s employer from the Company or any Affiliate, or (iii) any leave of absence authorized in writing by the Company prior to its commencement; provided, however, that for purposes of
Incentive Stock Options, no such leave may exceed 90 days, unless reemployment upon expiration of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, on
the 91st day of such leave any Incentive Stock Option held by the Participant shall cease to be treated as an Incentive Stock Option and shall be treated for tax purposes as a Nonstatutory Stock Option. Whether military, government or other service
or other leave of absence shall constitute a termination of Continuous Status as a Participant shall be determined in each case by the Committee at its discretion, and any determination by the Committee shall be final and conclusive. 

  
 3 

 (m) “Deferred Stock Unit” means a right granted to a
Participant under Article 9 to receive Shares (or the equivalent value in cash or other property if the Committee so provides) at a future time as determined by the Committee, or as determined by the Participant within guidelines established by the
Committee in the case of voluntary deferral elections. 
 (n) “Disability” of a Participant
means that the Participant (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous
period of not less than 12 months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months,
receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of the Participant’s employer. If the determination of Disability relates to an Incentive Stock Option,
Disability means Permanent and Total Disability as defined in Section 22(e)(3) of the Code. In the event of a dispute, the determination of whether a Participant is Disabled will be made by the Committee and may be supported by the advice of a
physician competent in the area to which such Disability relates. 
 (o) “Dividend Equivalent”
means a right granted to a Participant under Article 11. 
 (p) “Eligible Participant” means an
employee, officer, consultant or director of the Company or any Affiliate. 
 (q) “Exchange”
means any national securities exchange on which the Stock may from time to time be listed or traded. 
 (r)
“Fair Market Value,” on any date, means (i) if the Stock is listed on a securities exchange, the closing sales price on such exchange or over such system on such date or, in the absence of reported sales on such date, the
closing sales price on the immediately preceding date on which sales were reported, or (ii) if the Stock is not listed on a securities exchange, the mean between the bid and offered prices as quoted by the applicable interdealer quotation
system for such date, provided that if the Stock is not quoted on such interdealer quotation system or it is determined that the fair market value is not properly reflected by such quotations, Fair Market Value will be determined by such other
method as the Committee determines in good faith to be reasonable and in compliance with Code Section 409A. 

(s) “Full Value Award” means an Award other than in the form of an Option or SAR, and which is settled by
the issuance of Stock (or at the discretion of the Committee, settled in cash valued by reference to Stock value). 
 (t) “Grant Date” of an Award means the first date on which all necessary corporate action has been taken to approve the grant of the Award as provided in the Plan, or such later date as
is determined and specified as part of that authorization process. Notice of the grant shall be provided to the grantee within a reasonable time after the Grant Date. 

(u) “Incentive Stock Option” means an Option that is intended to be an incentive stock option and meets
the requirements of Section 422 of the Code or any successor provision thereto. 
 (v) “Independent
Director” means a director of the Company who is not a common law employee of the Company and who meets the additional requirements set forth for an 

  
 4 

 
“independent director” in the Charter. 
 (w)
“Nonstatutory Stock Option” means an Option that is not an Incentive Stock Option. 
 (x)
“Option” means a right granted to a Participant under Article 7 of the Plan to purchase Stock at a specified price during specified time periods. An Option may be either an Incentive Stock Option or a Nonstatutory Stock Option.

 (y) “Other Stock-Based Award” means a right granted to a Participant under Article 12 that
relates to or is valued by reference to Stock or other Awards relating to Stock. 
 (z) “Parent”
means a corporation, limited liability company, partnership or other entity which owns or beneficially owns a majority of the outstanding voting stock or voting power of the Company. Notwithstanding the above, with respect to an Incentive Stock
Option, Parent shall have the meaning set forth in Section 424(e) of the Code. 
 (aa)
“Participant” means a person who, as an employee, officer, director or consultant of the Company or any Affiliate, has been granted an Award under the Plan; provided that in the case of the death of a Participant, the term
“Participant” refers to a beneficiary designated pursuant to Section 13.4 or the legal guardian or other legal representative acting in a fiduciary capacity on behalf of the Participant under applicable state law and court
supervision. 
 (bb) “Performance Award” means any award granted under the Plan pursuant to
Article 10. 
 (cc) “Person” means any individual, entity or group, within the meaning of
Section 3(a)(9) of the 1934 Act and as used in Section 13(d)(3) or 14(d)(2) of the 1934 Act. 
 (dd)
“Plan” means the O’Donnell Strategic Industrial REIT, Inc. Long Term Incentive Plan, as amended from time to time. 
 (ee) “Plan Effective Date” has the meaning assigned such term in Section 3.1. 
 (ff) “Public Offering” shall occur on the closing date of a public offering of any class or series of the Company’s equity securities pursuant to a registration statement filed by
the Company under the 1933 Act. 
 (gg) “Restricted Stock” means Stock granted to a Participant
under Article 9 that is subject to certain restrictions and to risk of forfeiture. 
 (hh) “Restricted
Stock Unit” means a right granted to a Participant under Article 9 to receive shares of Stock (or the equivalent value in cash or other property if the Committee so provides) in the future, which right is subject to certain restrictions and
to risk of forfeiture. 
 (ii) “Shares” means shares of the Company’s Stock. If there has
been an adjustment or substitution pursuant to Section 14.1, the term “Shares” shall also include any shares of stock or other securities that are substituted for Shares or into which Shares are adjusted pursuant to Section 14.1.

 (jj) “Stock” means the $0.01 par value common stock of the Company and such

  
 5 

 
other securities of the Company as may be substituted for Stock pursuant to Section 14.1. 
 (kk) “Stock Appreciation Right” or “SAR” means a right granted to a Participant under Article 8 to receive a payment equal to the difference between the Fair Market Value of a
Share as of the date of exercise of the SAR over the grant price of the SAR, all as determined pursuant to Article 8. 
 (ll) “Subsidiary” means any corporation, limited liability company, partnership or other entity of which a majority of the outstanding voting stock or voting power is beneficially owned
directly or indirectly by the Company. Notwithstanding the above, with respect to an Incentive Stock Option, Subsidiary shall have the meaning set forth in Section 424(f) of the Code. 

(mm) “1933 Act” means the Securities Act of 1933, as amended from time to time. 

(nn) “1934 Act” means the Securities Exchange Act of 1934, as amended from time to time. 

ARTICLE 3 

PLAN EFFECTIVE DATE; TERMINATION OF PLAN 
 3.1. PLAN EFFECTIVE DATE. The Plan shall be effective as of the date it is approved by both the Board and the stockholders of the Company (the “Plan Effective Date”). 

3.2. TERMINATION OF PLAN. The Plan shall terminate on the tenth anniversary of the Plan Effective Date unless earlier terminated
as provided herein. The termination of the Plan on such date shall not affect the validity of any Award outstanding on the date of termination, which shall continue to be governed by the applicable terms and conditions of this Plan. Notwithstanding
the foregoing, no Incentive Stock Options may be granted more than ten (10) years after the earlier of (a) adoption of this Plan by the Board, or (b) the Plan Effective Date. 

ARTICLE 4 

ADMINISTRATION 
 4.1. COMMITTEE. The Plan shall be administered by a Committee appointed by the Board (which Committee shall consist of at least two directors) or, at the discretion of the Board from time to time,
the Plan may be administered by the Board. The members of the Committee shall be appointed by, and may be changed at any time and from time to time in the discretion of, the Board. It is intended that at least two of the directors appointed to serve
on the Committee shall be “non-employee directors” (within the meaning of Rule 16b-3 promulgated under the 1934 Act) and that any such members of the Committee who do not so qualify shall abstain from participating in any decision to make
or administer Awards that are made to Eligible Participants who at the time of consideration for such Award are persons subject to the short-swing profit rules of Section 16 of the 1934 Act. However, the mere fact that a Committee member shall
fail to qualify as a “non-employee director” or shall fail to abstain from such action shall not invalidate any Award made by the Committee which Award is otherwise validly made under the Plan. The members of the Committee shall be
appointed by, and may be changed at any time and from time to time in the discretion of, the Board. The Board may reserve to itself any or all of the authority and responsibility of the Committee under the Plan or may act as administrator of the
Plan for any and all purposes. To the extent the Board has reserved any authority and responsibility or during any time that the Board is acting as administrator of the Plan, it shall have all the powers of the Committee hereunder, and any reference
herein to the Committee (other than in this Section 4.1) shall include the Board. To the extent any action of the Board under the Plan conflicts with actions taken by the 

  
 6 

 
Committee, the actions of the Board shall control. 
 4.2. ACTION AND
INTERPRETATIONS BY THE COMMITTEE. For purposes of administering the Plan, the Committee may from time to time adopt rules, regulations, guidelines and procedures for carrying out the provisions and purposes of the Plan and make such other
determinations, not inconsistent with the Plan, as the Committee may deem appropriate. The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any Award in the manner and to the extent it deems
necessary to carry out the intent of the Plan. The Committee’s interpretation of the Plan, any Awards granted under the Plan, any Award Certificate and all decisions and determinations by the Committee with respect to the Plan are final,
binding, and conclusive on all parties. Each member of the Committee is entitled to, in good faith, rely or act upon any report or other information furnished to that member by any officer or other employee of the Company or any Affiliate, the
Company’s or an Affiliate’s independent certified public accountants, Company counsel or any executive compensation consultant or other professional retained by the Company to assist in the administration of the Plan. 

4.3. AUTHORITY OF COMMITTEE. The Committee has the exclusive power, authority and discretion to: 

(a) grant Awards; 
 (b) designate Participants; 
 (c) determine the type or types of
Awards to be granted to each Participant; 
 (d) determine the number of Awards to be granted and the number of
Shares or dollar amount to which an Award will relate; 
 (e) determine the terms and conditions of any Award
granted under the Plan; 
 (f) prescribe the form of each Award Certificate, which need not be identical for each
Participant; 
 (g) decide all other matters that must be determined in connection with an Award; 

(h) establish, adopt or revise any rules, regulations, guidelines or procedures as it may deem necessary or advisable to
administer the Plan; 
 (i) make all other decisions and determinations that may be required under the Plan or as
the Committee deems necessary or advisable to administer the Plan; 
 (j) amend the Plan or any Award Certificate
as provided herein; and 
 (k) adopt such modifications, procedures, and subplans as may be necessary or
desirable to comply with provisions of the laws of non-U.S. jurisdictions in which the Company or any Affiliate may operate, in order to assure the viability of the benefits of Awards granted to participants located in such other jurisdictions and
to meet the objectives of the Plan. 
 4.4. AWARD CERTIFICATES. Each Award shall be evidenced by an Award Certificate.
Each Award Certificate shall include such provisions, not inconsistent with the Plan, as may be specified by the Committee. 

  
 7 

 ARTICLE 5 
 SHARES SUBJECT TO THE PLAN 
 5.1. NUMBER OF SHARES. Subject to
adjustment as provided in Sections 5.2 and Section 14.1, the aggregate number of Shares reserved and available for issuance pursuant to Awards granted under the Plan shall be 300,000. The maximum number of Shares that may be issued upon
exercise of Incentive Stock Options granted under the Plan shall be 300,000. 
 5.2. SHARE COUNTING. Shares
covered by an Award shall be subtracted from the Plan share reserve as of the date of grant, but shall be added back to the Plan share reserve in accordance with this Section 5.2. 

(a) To the extent that an Award is canceled, terminates, expires, is forfeited or lapses for any reason, any unissued or forfeited Shares
originally subject to the Award will be added back to the Plan share reserve and again be available for issuance pursuant to Awards granted under the Plan. 
 (b) Shares subject to Awards settled in cash will be added back to the Plan share reserve and again be available for issuance pursuant to Awards granted under the Plan. 

(c) Shares withheld or repurchased from an Award or delivered by a Participant to satisfy minimum tax withholding requirements will be
added back to the Plan share reserve and again be available for issuance pursuant to Awards granted under the Plan. 
 (d) If
the exercise price of an Option is satisfied in whole or in part by delivering Shares to the Company (by either actual delivery or attestation), the number of Shares so tendered (by delivery or attestation) shall be added to the Plan share reserve
and will be available for issuance pursuant to Awards granted under the Plan. 
 (e) To the extent that the full number of
Shares subject to an Option or SAR is not issued upon exercise of the Option or SAR for any reason, including by reason of net-settlement of the Award, the unissued Shares originally subject to the Award will be added back to the Plan share reserve
and again be available for issuance pursuant to other Awards granted under the Plan. 
 (f) To the extent that the full number
of Shares subject to an Award other than an Option or SAR is not issued for any reason, including by reason of failure to achieve maximum performance goals, the unissued Shares originally subject to the Award will be added back to the Plan share
reserve and again be available for issuance pursuant to Awards granted under the Plan. 
 (g) Substitute Awards granted pursuant
to Section 13.10 of the Plan shall not count against the Shares otherwise available for issuance under the Plan under Section 5.1. 
 5.3. STOCK DISTRIBUTED. Any Stock distributed pursuant to an Award may consist, in whole or in part, of authorized and unissued Stock, treasury Stock or Stock purchased on the open market.

 ARTICLE 6 
 ELIGIBILITY 
 6.1. GENERAL. Awards may be granted only to Eligible
Participants. Incentive Stock Options may be granted only to Eligible Participants who are employees of the Company or a Parent or Subsidiary as defined in Section 424(e) and (f) of the Code. Eligible Participants who are service providers
to an Affiliate may be granted Options or SARs under this Plan only if the Affiliate qualifies as 

  
 8 

 an “eligible issuer of service recipient stock” within the meaning of §1.409A-1(b)(5)(iii)(E)
of the final regulations under Code Section 409A. 
 ARTICLE 7 

STOCK OPTIONS 
 7.1. GENERAL. The Committee is authorized to grant Options to Participants on the following terms and conditions: 

(a) EXERCISE PRICE. The exercise price per Share under an Option shall be determined by the Committee, provided
that the exercise price for any Option (other than an Option issued as a substitute Award pursuant to Section 13.10) shall not be less than the Fair Market Value as of the Grant Date. 

(b) PROHIBITION ON REPRICING. Except as otherwise provided in Section 14.1, the exercise price of an Option
may not be reduced, directly or indirectly by cancellation and regrant or otherwise, without the prior approval of the stockholders of the Company. 
 (c) TIME AND CONDITIONS OF EXERCISE. The Committee shall determine the time or times at which an Option may be exercised in whole or in part, subject to Section 7.1(e). The Committee shall
also determine the performance or other conditions, if any, that must be satisfied before all or part of an Option may be exercised or vested. 
 (d) PAYMENT. The Committee shall determine the methods by which the exercise price of an Option may be paid, the form of payment, including, without limitation, cash, Shares, or other property
(including “cashless exercise” arrangements), and the methods by which Shares shall be delivered or deemed to be delivered to Participants. 
 (e) EXERCISE TERM. Except for Nonstatutory Options granted to Participants outside the United States, no Option granted under the Plan shall be exercisable for more than ten years from the Grant
Date. 
 (f) NO DEFERRAL FEATURE. No Option shall provide for any feature for the deferral of compensation
other than the deferral of recognition of income until the exercise or disposition of the Option. 
 (g) NO
DIVIDEND EQUIVALENTS. No Option shall provide for Dividend Equivalents. 
 7.2. INCENTIVE STOCK OPTIONS. The terms of
any Incentive Stock Options granted under the Plan must comply with the requirements of Section 422 of the Code. If all of the requirements of Section 422 of the Code are not met, the Option shall automatically become a Nonstatutory Stock
Option. 
 ARTICLE 8 
 STOCK APPRECIATION RIGHTS 
 8.1. GRANT OF STOCK APPRECIATION RIGHTS.
The Committee is authorized to grant Stock Appreciation Rights to Participants on the following terms and conditions: 
 (a) RIGHT TO PAYMENT. Upon the exercise of a SAR, the Participant to whom it 

  
 9 

 
is granted has the right to receive, for each Share with respect to which the SAR is being exercised, the excess, if any, of: 

(1) The Fair Market Value of one Share on the date of exercise; over 

(2) The base price of the SAR as determined by the Committee, which shall not be less than the Fair Market Value of one
Share on the Grant Date. 
 (b) PROHIBITION ON REPRICING. Except as otherwise provided in
Section 14.1, the base price of a SAR may not be reduced, directly or indirectly by cancellation and regrant or otherwise, without the prior approval of the stockholders of the Company. 

(c) TIME AND CONDITIONS OF EXERCISE. The Committee shall determine the time or times at which a SAR may be
exercised in whole or in part. Except for SARs granted to Participants outside the United States, no SAR shall be exercisable for more than ten years from the Grant Date. 

(d) NO DEFERRAL FEATURE. No SAR shall provide for any feature for the deferral of compensation other than the
deferral of recognition of income until the exercise or disposition of the SAR. 
 (e) NO DIVIDEND
EQUIVALENTS. No SAR shall provide for Dividend Equivalents. 
 (f) OTHER TERMS. All SARs shall be
evidenced by an Award Certificate. Subject to the limitations of this Article 8, the terms, methods of exercise, methods of settlement, form of consideration payable in settlement, and any other terms and conditions of any SAR shall be determined by
the Committee at the time of the grant of the Award and shall be reflected in the Award Certificate. 
 ARTICLE 9

 RESTRICTED STOCK, RESTRICTED STOCK UNITS 
 AND DEFERRED STOCK UNITS 
 9.1. GRANT OF RESTRICTED STOCK, RESTRICTED
STOCK UNITS AND DEFERRED STOCK UNITS. The Committee is authorized to make Awards of Restricted Stock, Restricted Stock Units or Deferred Stock Units to Participants in such amounts and subject to such terms and conditions as may be selected by
the Committee. An Award of Restricted Stock, Restricted Stock Units or Deferred Stock Units shall be evidenced by an Award Certificate setting forth the terms, conditions, and restrictions applicable to the Award. 

9.2. ISSUANCE AND RESTRICTIONS. Restricted Stock, Restricted Stock Units or Deferred Stock Units shall be subject to such
restrictions on transferability and other restrictions as the Committee may impose (including, without limitation, limitations on the right to vote Restricted Stock or the right to receive dividends on the Restricted Stock). These restrictions may
lapse separately or in combination at such times, under such circumstances, in such installments, upon the satisfaction of performance goals or otherwise, as the Committee determines at the time of the grant of the Award or thereafter. Except as
otherwise provided in an Award Certificate or any special Plan document governing an Award, the Participant shall have all of the rights of a stockholder with respect to the Restricted Stock, and the Participant shall have none of the rights of a
stockholder with respect to Restricted Stock Units or Deferred Stock Units until such time as Shares of Stock are paid in settlement of the Restricted Stock 

  
 10 

 Units or Deferred Stock Units. 
 9.3 DIVIDENDS ON RESTRICTED STOCK. In the case of Restricted Stock, the Committee may provide that ordinary cash dividends declared on the Shares before they are vested (i) will be forfeited,
(ii) will be deemed to have been reinvested in additional Shares or otherwise reinvested (subject to Share availability under Section 5.1 hereof), or (iii) in the case of Restricted Stock that is not subject to performance-based
vesting, will be paid or distributed to the Participant as accrued (in which case, such dividends must be paid or distributed no later than the 15th day of the 3rd month following the later of (A) the calendar year in which the corresponding
dividends were paid to shareholders, or (B) the first calendar year in which the Participant’s right to such dividends is no longer subject to a substantial risk of forfeiture). Unless otherwise provided by the Committee, dividends accrued
on Shares of Restricted Stock before they are vested shall, as provided in the Award Certificate, either (i) be reinvested in the form of additional Shares, which shall be subject to the same vesting provisions as provided for the host Award,
or (ii) be credited by the Company to an account for the Participant and accumulated without interest until the date upon which the host Award becomes vested, and any dividends accrued with respect to forfeited Restricted Stock will be
reconveyed to the Company without further consideration or any act or action by the Participant. 
 9.4. FORFEITURE.
Except as otherwise determined by the Committee at the time of the grant of the Award or thereafter, upon termination of Continuous Status as a Participant during the applicable restriction period or upon failure to satisfy a performance goal during
the applicable restriction period, Restricted Stock or Restricted Stock Units that are at that time subject to restrictions shall be forfeited. 
 9.5. DELIVERY OF RESTRICTED STOCK. Shares of Restricted Stock shall be delivered to the Participant at Grant Date either by book-entry registration or by delivering to the Participant, or a
custodian or escrow agent (including, without limitation, the Company or one or more of its employees) designated by the Committee, a stock certificate or certificates registered in the name of the Participant. If physical certificates representing
shares of Restricted Stock are registered in the name of the Participant, such certificates must bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Stock. 

ARTICLE 10 

PERFORMANCE AWARDS 
 10.1. GRANT OF PERFORMANCE AWARDS. The Committee is authorized to grant any Award under this Plan, including cash-based Awards, with performance-based vesting criteria, on such terms and conditions
as may be selected by the Committee. Any such Awards with performance-based vesting criteria are referred to herein as Performance Awards. The Committee shall have the complete discretion to determine the number of Performance Awards granted to each
Participant and to designate the provisions of such Performance Awards as provided in Section 4.3. All Performance Awards shall be evidenced by an Award Certificate or a written program established by the Committee, pursuant to which
Performance Awards are awarded under the Plan under uniform terms, conditions and restrictions set forth in such written program. 
 10.2. PERFORMANCE GOALS. The Committee may establish performance goals for Performance Awards which may be based on any criteria selected by the Committee. Such performance goals may be described
in terms of Company-wide objectives or in terms of objectives that relate to the performance of the Participant, an Affiliate or a division, region, department or function within the Company or an Affiliate. If the Committee determines that a change
in the business, operations, corporate structure or capital structure of the Company or the manner in which the Company or an Affiliate 

  
 11 

 conducts its business, or other events or circumstances render performance goals to be unsuitable, the
Committee may modify such performance goals in whole or in part, as the Committee deems appropriate. If a Participant is promoted, demoted or transferred to a different business unit or function during a performance period, the Committee may
determine that the performance goals or performance period are no longer appropriate and may (i) adjust, change or eliminate the performance goals or the applicable performance period as it deems appropriate to make such goals and period
comparable to the initial goals and period, or (ii) make a cash payment to the participant in an amount determined by the Committee. 
 ARTICLE 11 
 DIVIDEND EQUIVALENTS 

11.1. GRANT OF DIVIDEND EQUIVALENTS. Except as provided in Sections 7.1(g) and 8.1(e), the Committee is
authorized to grant Dividend Equivalents with respect to Full-Value Awards granted hereunder, subject to such terms and conditions as may be selected by the Committee. Dividend Equivalents shall entitle the Participant to receive payments equal to
dividends with respect to all or a portion of the number of Shares subject to a Full-Value Award, as determined by the Committee. The Committee may provide that Dividend Equivalents be paid or distributed when accrued or be deemed to have been
reinvested in additional Shares, or otherwise reinvested. Unless otherwise provided in the applicable Award Certificate, Dividend Equivalents will be paid or distributed no later than the 15th day of the 3rd month following the later of (i) the calendar year in which the corresponding dividends were paid to
stockholders, or (ii) the first calendar year in which the Participant’s right to such Dividends Equivalents is no longer subject to a substantial risk of forfeiture. 
 ARTICLE 12 
 OTHER AWARDS 

12.1. GRANT OF OTHER AWARDS. The Committee is authorized, subject to limitations under applicable law, to grant to Participants
such other Awards that are payable in, valued in whole or in part by reference to, or otherwise based on or related to Shares, as deemed by the Committee to be consistent with the purposes of the Plan, including without limitation, membership
interests in a Subsidiary or operating partnership, Shares awarded purely as a “bonus” and not subject to any restrictions or conditions, convertible or exchangeable debt securities, other rights convertible or exchangeable into Shares,
and Awards valued by reference to book value of Shares or the value of securities of or the performance of specified Parents or Subsidiaries. The Committee shall determine the terms and conditions of such Awards. 

ARTICLE 13 

PROVISIONS APPLICABLE TO AWARDS 
 13.1. AWARD CERTIFICATES. Each Award shall be evidenced by an Award Certificate. Each Award Certificate shall include such provisions, not inconsistent with the Plan, as may be specified by the
Committee. 
 13.2. FORM OF PAYMENT FOR AWARDS. At the discretion of the Committee, payment of Awards may be made in
cash, Stock, a combination of cash and Stock, or any other form of property as the Committee shall determine. In addition, payment of Awards may include such terms, conditions, restrictions and/or limitations, if any, as the Committee deems
appropriate, including, in the case of Awards paid in the form of Stock, restrictions on transfer and forfeiture provisions. Further, payment of Awards may be made in the form of a lump sum, or in installments, as determined by the Committee.

 13.3. LIMITS ON TRANSFER. No right or interest of a Participant in any unexercised or 

  
 12 

 restricted Award may be pledged, encumbered, or hypothecated to or in favor of any party other than the
Company or an Affiliate, or shall be subject to any lien, obligation, or liability of such Participant to any other party other than the Company or an Affiliate. No unexercised or restricted Award shall be assignable or transferable by a Participant
other than by will or the laws of descent and distribution; provided, however, that the Committee may (but need not) permit other transfers (other than transfers for value) where the Committee concludes that such transferability
(i) does not result in accelerated taxation, (ii) does not cause any Option intended to be an Incentive Stock Option to fail to be described in Code Section 422(b), and (iii) is otherwise appropriate and desirable, taking into
account any factors deemed relevant, including without limitation, state or federal tax or securities laws applicable to transferable Awards. 
 13.4. BENEFICIARIES. Notwithstanding Section 13.3, a Participant may, in the manner determined by the Committee, designate a beneficiary to exercise the rights of the Participant and to
receive any distribution with respect to any Award upon the Participant’s death. A beneficiary, legal guardian, legal representative, or other person claiming any rights under the Plan is subject to all terms and conditions of the Plan and any
Award Certificate applicable to the Participant, except to the extent the Plan and Award Certificate otherwise provide, and to any additional restrictions deemed necessary or appropriate by the Committee. If no beneficiary has been designated or
survives the Participant, payment shall be made to the Participant’s estate. Subject to the foregoing, a beneficiary designation may be changed or revoked by a Participant at any time provided the change or revocation is filed with the
Committee. 
 13.5. STOCK TRADING RESTRICTIONS. All Stock issuable under the Plan is subject to any stop-transfer orders
and other restrictions as the Committee deems necessary or advisable to comply with federal or state securities laws, rules and regulations and the rules of any national securities exchange or automated quotation system on which the Stock is listed,
quoted, or traded. The Committee may place legends on any Stock certificate or issue instructions to the transfer agent to reference restrictions applicable to the Stock. 
 13.6. ACCELERATION UPON DEATH OR DISABILITY. Except as otherwise provided in the Award Certificate or any special Plan document governing an Award, upon the termination of a person’s
Continuous Status as a Participant by reason of death or Disability: 
 (i) all of that Participant’s
outstanding Options and SARs shall become fully exercisable; 
 (ii) all time-based vesting restrictions on that
Participant’s outstanding Awards shall lapse as of the date of termination; and 
 (iii) the payout
opportunities attainable under all of that Participant’s outstanding performance-based Awards shall be deemed to have been fully earned as of the date of termination as follows: 

(A) if the date of termination occurs during the first half of the applicable performance period, all relevant performance
goals will be deemed to have been achieved at the “target” level, and 
 (B) if the date of termination
occurs during the second half of the applicable performance period, the actual level of achievement of all relevant performance goals against target will be measured as of the end of the calendar quarter immediately preceding the date of
termination, and 

  
 13 

 (C) in either such case, there shall be a pro rata payout to the Participant
or his or her estate within sixty (60) days following the date of termination (unless a later date is required by Section 16.3 hereof), based upon the length of time within the performance period that has elapsed prior to the date of
termination. 
 To the extent that this provision causes Incentive Stock Options to exceed the dollar limitation set forth in
Code Section 422(d), the excess Options shall be deemed to be Nonstatutory Stock Options. 
 13.7. ACCELERATION UPON A
CHANGE IN CONTROL. Except as otherwise provided in the Award Certificate or any special Plan document governing an Award, upon the occurrence of a Change in Control, (i) all outstanding Options, SARs, and other Awards in the nature of
rights that may be exercised shall become fully exercisable, and (ii) all time-based vesting restrictions on outstanding Awards shall lapse. Except as otherwise provided in the Award Certificate or any special Plan document governing an Award,
upon the occurrence of a Change in Control, the target payout opportunities attainable under all outstanding performance-based Awards shall be deemed to have been fully earned as of the effective date of the Change in Control based upon an assumed
achievement of all relevant performance goals at the “target” level and there shall be a pro rata payout to Participants within thirty (30) days following the effective date of the Change in Control based upon the length of time
within the performance period that has elapsed prior to the Change in Control. 
 13.8. ACCELERATION FOR ANY REASON. The
Committee may in its sole discretion at any time determine that all or a portion of a Participant’s Options, SARs, and other Awards in the nature of rights that may be exercised shall become fully or partially exercisable, that all or a part of
the time-based vesting restrictions on all or a portion of the outstanding Awards shall lapse, and/or that any performance-based criteria with respect to any Awards shall be deemed to be wholly or partially satisfied, in each case, as of such date
as the Committee may, in its sole discretion, declare. The Committee may discriminate among Participants and among Awards granted to a Participant in exercising its discretion pursuant to this Section 13.8. Notwithstanding anything in the Plan,
including this Section 13.8, the Committee may not accelerate the payment of any Award if such acceleration would violate Section 409A(a)(3) of the Code. 
 13.9. FORFEITURE EVENTS. The Committee may specify in an Award Certificate that the Participant’s rights, payments and benefits with respect to an Award shall be subject to reduction,
cancellation, forfeiture or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events shall include, but shall not be limited to, termination of
employment for Cause, violation of material Company or Affiliate policies, breach of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental to the
business or reputation of the Company or any Affiliate. 
 13.10. SUBSTITUTE AWARDS. The Committee may grant Awards under
the Plan in substitution for stock and stock-based awards held by employees of another entity who become employees of the Company or an Affiliate as a result of a merger or consolidation of the former employing entity with the Company or an
Affiliate or the acquisition by the Company or an Affiliate of property or stock of the former employing corporation. The Committee may direct that the substitute awards be granted on such terms and conditions as the Committee considers appropriate
in the circumstances. 

  
 14 

 ARTICLE 14 
 CHANGES IN CAPITAL STRUCTURE 
 14.1. MANDATORY ADJUSTMENTS. In the
event of a nonreciprocal transaction between the Company and its stockholders that causes the per-share value of the Stock to change (including, without limitation, any stock dividend, stock split, spin-off, rights offering, or large nonrecurring
cash dividend), the authorization limits under Section 5.1 shall be adjusted proportionately, and the Committee shall make such adjustments to the Plan and Awards as it deems necessary, in its sole discretion, to prevent dilution or enlargement
of rights immediately resulting from such transaction. Action by the Committee may include: (i) adjustment of the number and kind of shares that may be delivered under the Plan; (ii) adjustment of the number and kind of shares subject to
outstanding Awards; (iii) adjustment of the exercise price of outstanding Awards or the measure to be used to determine the amount of the benefit payable on an Award; and (iv) any other adjustments that the Committee determines to be
equitable. Notwithstanding the foregoing, the Committee shall not make any adjustments to outstanding Options or SARs that would constitute a modification or substitution of the stock right under Treas. Reg. Sections 1.409A-1(b)(5)(v) that would be
treated as the grant of a new stock right or change in the form of payment for purposes of Code Section 409A. Without limiting the foregoing, in the event of a subdivision of the outstanding Stock (stock-split), a declaration of a dividend
payable in Shares, or a combination or consolidation of the outstanding Stock into a lesser number of Shares, the authorization limits under Section 5.1 shall automatically be adjusted proportionately, and the Shares then subject to each Award
shall automatically, without the necessity for any additional action by the Committee, be adjusted proportionately without any change in the aggregate purchase price therefor. 
 14.2. DISCRETIONARY ADJUSTMENTS. Upon the occurrence or in anticipation of any corporate event or transaction involving the Company (including, without limitation, any merger, reorganization,
recapitalization, combination or exchange of shares, or any transaction described in Section 14.1), the Committee may, in its sole discretion, provide (i) that Awards will be settled in cash rather than Stock, (ii) that Awards will
become immediately vested and exercisable and will expire after a designated period of time to the extent not then exercised, (iii) that Awards will be assumed by another party to a transaction or otherwise be equitably converted or substituted
in connection with such transaction, (iv) that outstanding Awards may be settled by payment in cash or cash equivalents equal to the excess of the Fair Market Value of the underlying Stock, as of a specified date associated with the
transaction, over the exercise price of the Award, (v) that performance targets and performance periods for Performance Awards will be modified, or (vi) any combination of the foregoing. The Committee’s determination need not be
uniform and may be different for different Participants whether or not such Participants are similarly situated. 
 14.3.
GENERAL. Any discretionary adjustments made pursuant to this Article 14 shall be subject to the provisions of Section 15.2. To the extent that any adjustments made pursuant to this Article 14 cause Incentive Stock Options to cease to
qualify as Incentive Stock Options, such Options shall be deemed to be Nonstatutory Stock Options. 
 ARTICLE 15

 AMENDMENT, MODIFICATION AND TERMINATION 
 15.1. AMENDMENT, MODIFICATION AND TERMINATION. The Board or the Committee may, at any time and from time to time, amend, modify or terminate the Plan without stockholder approval; provided,
however, that if an amendment to the Plan would, in the reasonable opinion of the Board or the Committee, either (i) materially increase the number of Shares available under the Plan, (ii) expand the types of awards under the Plan,
(iii) materially expand the class of participants eligible to participate in the Plan, (iv) materially extend the term of the Plan, or (v) otherwise constitute a material 

  
 15 

 change requiring stockholder approval under applicable laws, policies or regulations or the applicable
listing or other requirements of an Exchange, then such amendment shall be subject to stockholder approval; and provided, further, that the Board or Committee may condition any other amendment or modification on the approval of
stockholders of the Company for any reason, including by reason of such approval being necessary or deemed advisable (i) to comply with the listing or other requirements of an Exchange, or (ii) to satisfy any other tax, securities or other
applicable laws, policies or regulations. 
 15.2. AWARDS PREVIOUSLY GRANTED. At any time and from time to time, the
Committee may amend, modify or terminate any outstanding Award without approval of the Participant; provided, however: 
 (a) Subject to the terms of the applicable Award Certificate, such amendment, modification or termination shall not, without the Participant’s consent, reduce or diminish the value of such Award
determined as if the Award had been exercised, vested, cashed in or otherwise settled on the date of such amendment or termination (with the per-share value of an Option or SAR for this purpose being calculated as the excess, if any, of the Fair
Market Value as of the date of such amendment or termination over the exercise or base price of such Award); 

(b) The original term of an Option or SAR may not be extended without the prior approval of the stockholders of the
Company; 
 (c) Except as otherwise provided in Section 14.1, the exercise price of an Option or SAR may not
be reduced, directly or indirectly, without the prior approval of the stockholders of the Company; and 
 (d) No
termination, amendment, or modification of the Plan shall adversely affect any Award previously granted under the Plan, without the written consent of the Participant affected thereby. An outstanding Award shall not be deemed to be “adversely
affected” by a Plan amendment if such amendment would not reduce or diminish the value of such Award determined as if the Award had been exercised, vested, cashed in or otherwise settled on the date of such amendment (with the per-share value
of an Option or SAR for this purpose being calculated as the excess, if any, of the Fair Market Value as of the date of such amendment over the exercise or base price of such Award). 

15.3. COMPLIANCE AMENDMENTS. Notwithstanding anything in the Plan or in any Award Certificate to the contrary, the Board may amend
the Plan or an Award Certificate, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or Award Certificate to any present or future law relating to plans of this or similar nature
(including, but not limited to, Section 409A of the Code), and to the administrative regulations and rulings promulgated thereunder. By accepting an Award under this Plan, a Participant agrees to any amendment made pursuant to this
Section 15.3 to any Award granted under the Plan without further consideration or action. 
 ARTICLE 16 

GENERAL PROVISIONS 
  

	 	16.1.	RIGHTS OF PARTICIPANTS. 

 (a) No Participant or any Eligible Participant shall have any claim to be granted any Award under the Plan. Neither the Company, its Affiliates nor the Committee is obligated to treat Participants or
Eligible Participants uniformly, and determinations made under the Plan may be 

  
 16 

 made by the Committee selectively among Eligible Participants who receive, or are eligible
to receive, Awards (whether or not such Eligible Participants are similarly situated). 
 (b) Nothing in the
Plan, any Award Certificate or any other document or statement made with respect to the Plan, shall interfere with or limit in any way the right of the Company or any Affiliate to terminate any Participant’s employment or status as an officer,
or any Participant’s service as a director, at any time, nor confer upon any Participant any right to continue as an employee, officer, or director of the Company or any Affiliate, whether for the duration of a Participant’s Award or
otherwise. 
 (c) Neither an Award nor any benefits arising under this Plan shall constitute an employment
contract with the Company or any Affiliate and, accordingly, subject to Article 15, this Plan and the benefits hereunder may be terminated at any time in the sole and exclusive discretion of the Committee without giving rise to any liability on the
part of the Company or an of its Affiliates. 
 (d) No Award gives a Participant any of the rights of a
stockholder of the Company unless and until Shares are in fact issued to such person in connection with such Award. 
 16.2.
WITHHOLDING. The Company or any Affiliate shall have the authority and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes (including the
Participant’s FICA obligation) required by law to be withheld with respect to any exercise, lapse of restriction or other taxable event arising as a result of the Plan. With respect to withholding required upon any taxable event under the Plan,
the Committee may, at the time the Award is granted or thereafter, require or permit that any such withholding requirement be satisfied, in whole or in part, by withholding from the Award Shares having a Fair Market Value on the date of withholding
equal to the minimum amount (and not any greater amount) required to be withheld for tax purposes, all in accordance with such procedures as the Committee establishes. All such elections shall be subject to any restrictions or limitations that the
Committee, in its sole discretion, deems appropriate. 
  

	 	16.3.	SPECIAL PROVISIONS RELATED TO SECTION 409A OF THE CODE. 

 (a) General. It is intended that the payments and benefits provided under the Plan and any Award shall either be exempt from the application of, or comply with, the requirements of
Section 409A of the Code. The Plan and all Award Certificates shall be construed in a manner that effects such intent. Nevertheless, the tax treatment of the benefits provided under the Plan or any Award is not warranted or guaranteed. Neither
the Company, its Affiliates nor their respective directors, officers, employees or advisers shall be held liable for any taxes, interest, penalties or other monetary amounts owed by any Participant or other taxpayer as a result of the Plan or any
Award. 
 (b) Definitional Restrictions. Notwithstanding anything in the Plan or in any Award Certificate to the
contrary, to the extent that any amount or benefit that would constitute non-exempt “deferred compensation” for purposes of Section 409A of the Code would otherwise be payable or distributable, or a different form of payment (e.g.,
lump sum or installment) would be effected, under the Plan or any Award Certificate by reason of the occurrence of a Change in Control, or the Participant’s Disability or separation from service, such amount or benefit will not be payable or
distributable to the Participant, and/or such different form of payment will not be effected, by reason of such circumstance unless the circumstances giving rise to such Change in Control, Disability or separation from service meet any description
or definition of “change in control event”, “disability” or “separation from service”, as the case may be, in Section 409A of the Code and applicable regulations (without giving effect to any elective provisions
that may be available under such definition). This provision does not prohibit the 

  
 17 

 vesting of any Award upon a Change in Control, Disability or separation from service, however defined. If
this provision prevents the payment or distribution of any amount or benefit, such payment or distribution shall be made on the next earliest payment or distribution date or event specified in the Award Certificate that is permissible under
Section 409A of the Code. If this provision prevents the application of a different form of payment of any amount or benefit, such payment shall be made in the same form as would have applied absent such designated event or circumstance.

 (c) Allocation among Possible Exemptions. If any one or more Awards granted under the Plan to a Participant could
qualify for any separation pay exemption described in Treas. Reg. Section 1.409A-1(b)(9), but such Awards in the aggregate exceed the dollar limit permitted for the separation pay exemptions, the Company (acting through the Committee) shall
determine which Awards or portions thereof will be subject to such exemptions. 
 (d) Six-Month Delay in Certain
Circumstances. Notwithstanding anything in the Plan or in any Award Certificate to the contrary, if any amount or benefit that would constitute non-exempt “deferred compensation” for purposes of Section 409A of the Code would
otherwise be payable or distributable under this Plan or any Award Certificate by reason of a Participant’s separation from service during a period in which the Participant is a Specified Employee (as defined below), then, subject to any
permissible acceleration of payment by the Committee under Treas. Reg. Section 1.409A-3(j)(4)(ii) (domestic relations order), (j)(4)(iii) (conflicts of interest), or (j)(4)(vi) (payment of employment taxes): 

(i) the amount of such non-exempt deferred compensation that would otherwise be payable during the six-month period
immediately following the Participant’s separation from service will be accumulated through and paid or provided on the first day of the seventh month following the Participant’s separation from service (or, if the Participant dies during
such period, within 30 days after the Participant’s death) (in either case, the “Required Delay Period”), and 
 (ii) the normal payment or distribution schedule for any remaining payments or distributions will resume at the end of the Required Delay Period. 

For purposes of this Plan, the term “Specified Employee” has the meaning given such term in Section 409A of
the Code and the final regulations thereunder, provided, however, that, as permitted in such final regulations, the Company’s Specified Employees and its application of the six-month delay rule of 409A(a)(2)(B)(i) of the Code
shall be determined in accordance with rules adopted by the Board or any committee of the Board, which shall be applied consistently with respect to all nonqualified deferred compensation arrangements of the Company, including this Plan. 

16.4. UNFUNDED STATUS OF AWARDS. The Plan is intended to be an “unfunded” plan for incentive and deferred compensation.
With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award Certificate shall give the Participant any rights that are greater than those of a general creditor of the Company or any
Affiliate. This Plan is not intended to be subject to ERISA. 
 16.5. RELATIONSHIP TO OTHER BENEFITS. No payment under
the Plan shall be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare or benefit plan of the Company or any Affiliate unless provided otherwise in such other plan.

 16.6. EXPENSES. The expenses of administering the Plan shall be borne by the Company and its Affiliates. 

  
 18 

 16.7. TITLES AND HEADINGS. The titles and headings of the Sections in the Plan are
for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control. 
 16.8. GENDER AND NUMBER. Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine; the plural shall include the singular and the singular
shall include the plural. 
 16.9. FRACTIONAL SHARES. No fractional Shares shall be issued and the Committee shall
determine, in its discretion, whether cash shall be given in lieu of fractional Shares or whether such fractional Shares shall be eliminated by rounding up or down. 
  

	 	16.10.	GOVERNMENT AND OTHER REGULATIONS. 

 (a) Notwithstanding any other provision of the Plan, no Participant who acquires Shares pursuant to the Plan may, during any period of time that such Participant is an affiliate of the Company (within the
meaning of the rules and regulations of the Securities and Exchange Commission under the 1933 Act), sell such Shares, unless such offer and sale is made (i) pursuant to an effective registration statement under the 1933 Act, which is current
and includes the Shares to be sold, or (ii) pursuant to an appropriate exemption from the registration requirement of the 1933 Act, such as that set forth in Rule 144 promulgated under the 1933 Act. 

(b) Notwithstanding any other provision of the Plan, if at any time the Committee shall determine that the registration,
listing or qualification of the Shares covered by an Award upon any Exchange or under any foreign, federal, state or local law or practice, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of,
or in connection with, the granting of such Award or the purchase or receipt of Shares thereunder, no Shares may be purchased, delivered or received pursuant to such Award unless and until such registration, listing, qualification, consent or
approval shall have been effected or obtained free of any condition not acceptable to the Committee. Any Participant receiving or purchasing Shares pursuant to an Award shall make such representations and agreements and furnish such information as
the Committee may request to assure compliance with the foregoing or any other applicable legal requirements. The Company shall not be required to issue or deliver any certificate or certificates for Shares under the Plan prior to the
Committee’s determination that all related requirements have been fulfilled. The Company shall in no event be obligated to register any securities pursuant to the 1933 Act or applicable state or foreign law or to take any other action in order
to cause the issuance and delivery of such certificates to comply with any such law, regulation or requirement. 
 16.11.
GOVERNING LAW. To the extent not governed by federal law, the Plan and all Award Certificates shall be construed in accordance with and governed by the laws of the State of Maryland. 

16.12. ADDITIONAL PROVISIONS. Each Award Certificate may contain such other terms and conditions as the Committee may determine;
provided that such other terms and conditions are not inconsistent with the provisions of the Plan. 
 16.13. NO LIMITATIONS
ON RIGHTS OF COMPANY. The grant of any Award shall not in any way affect the right or power of the Company to make adjustments, reclassification or changes in its capital or business structure or to merge, consolidate, dissolve, liquidate, sell
or transfer all or any part of its business or assets. The Plan shall not restrict the authority of the Company, for proper corporate 

  
 19 

 
purposes, to draft or assume awards, other than under the Plan, to or with respect to any person. If the Committee so directs, the Company may issue or transfer Shares to an Affiliate, for such
lawful consideration as the Committee may specify, upon the condition or understanding that the Affiliate will transfer such Shares to a Participant in accordance with the terms of an Award granted to such Participant and specified by the Committee
pursuant to the provisions of the Plan. 
 16.14. INDEMNIFICATION. Each person who is or shall have been a member of the
Committee or of the Board shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim,
action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by him or her in settlement thereof,
with the Company’s approval, or paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend
the same before he or she undertakes to handle and defend it on his or her own behalf, unless such loss, cost, liability, or expense is a result of his or her own willful misconduct or except as expressly provided by statute. The foregoing right of
indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company’s charter or bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify
them or hold them harmless. 
 ******************** 

  
 20 

 The foregoing is hereby acknowledged as being the O’Donnell Strategic Industrial REIT,
Inc. Long Term Incentive Plan as adopted by the Board on April 12, 2011, and by the stockholders on April 12, 2011. 
  

 

			
	 O’DONNELL STRATEGIC INDUSTRIAL REIT, INC.

		
	 By:
	 	 /s/     Christopher S. Cameron

	 Name:
	 	Christopher S. Cameron
	 Title:
	 	Chief Financial Officer and Treasurer

  
 21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}]]